经尿道前列腺等离子双极电切术治疗高龄高危前列腺增生症48例

Treatment of senior and high risk benign prostatic hyperplasia by transurethral plasmakinetic vaporization of prostate 48 cases

目的探讨经尿道前列腺等离子双极电切术(TUPKP)治疗高龄高危良性前列腺增生症(BPH)的临床疗效。方法 2011年3月～2012年12月,我院应用TUPKP治疗高龄高危BPH患者48例,观察手术时间、术中出血量、手术并发症、术后住院天数,记录并计算手术前后的国际前列腺症状评分(IPSS)、残余尿量改变等指标的差异。结果 48例患者均安全渡过围手术期,手术时间(45.0±25.6)min,切除腺体重(40.6±16.3)g,术中出血(100.0±62.5)mL。国际前列腺症状评分(IPSS)由术前(26.5±2.6)分降至术后(9.6±4.3)分,残余尿量由(223±25)mL降至(15.0±8.5)mL。随访3～24月,平均12个月,疗效满意。结论 TUPKP可作为高龄高危BPH患者安全有效的治疗方法,而非绝对禁忌证。

Objective To evaluate the effect of transurethral plasmakinetic vaporization of prostate （TUPKP） on senior and high risk benign prostatic hyperplasia. Methods TUPKP was performed in 48 senior and high risk patients with BPH from March 2011 to December 2012,and operation time,blood loss,surgical complications,postoperative hospital stay,international prostate symptom score（IPSS）and residual urine volume were recorded and calculated. Results All of the 48 cases passed perioperative period safely. Average operation time was（45 ±25.6） rain,average weight of resected tissue was（40.6 ± 16.3）g,and blood loss was （100 ± 62.5） mL.IPSS were （26.5 ±.8）and（ 9.6± 4.3）,and the residual urine were （223 ±25） mL and （15 ± 8.5） mL.All the patients had been followed up for 3-24 months with an average of 12 months. The effect was satisfactory. Conclusion It is suggested that TUPKP is safe and effective to deal with the patients with BPH in senior and high risk.